MedPath

E stablishment of a g e riatr i c a ssessment based m ultidisciplinary team app r oach o n hospitalized ol d er pati en ts with advanced solid cancer: a multicenter randomized clinical trial

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0006610
Lead Sponsor
Chung-Ang Univerisity Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
260
Inclusion Criteria

? Patients aged 65 or older and hospitalized for acute symptoms.
? Patients with confirmed senility or pre-aging (KFRAIL 1 point or more)
? High blood pressure, diabetes, ischemic heart disease, chronic lung disease, arthritis, cerebral infarction, depression, chronic kidney disease, dementia, cerebral infarction, etc. among the following diseases.
? A person who has lived in a house other than a nursing home for at least 3 months before hospitalization.
? Since local treatment surgery, radiation chemotherapy, radiation therapy, etc. for radical purposes are impossible, patient stage 3 or higher, which is subject to informal primary chemotherapy.
? Histologically confirmed as cancer, gastric adenocarcinoma, colon adenocarcinoma, lung cancer, non-small cells, small cell carcinoma, pancreatic adenocarcinoma, biliary tract adenocarcinoma

Exclusion Criteria

? When hospitalization is required in a special ward, such as an internal medicine intensive care unit, a cardiovascular intensive care unit, or an acute stroke ward, at the time of hospitalization.
? Patients who are not subject to conventional first-line chemotherapy.
? Patients who are subject to oral targeted therapy with conventional primary treatment.
? In the case where palliative hospice palliative care is required due to a terminal disease
? If your life expectancy is less than 6 months
? Patients who recur within 6 months of completion of assisted chemotherapy for the purpose of preventing recurrence after surgery.
? In the case where there are other serious reasons for restricting participation and progress of research at the discretion of the researcher

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall treatment utility
Secondary Outcome Measures
NameTimeMethod
Entering a long term care facility (nursing home, long term care hospital and etc) within 3 months after discharge;Geriatric syndrome during hospitalization;Validation of anticancer drug toxicity prediction model;reduce in total number of medications or inappropriate medication;Degree of recognition of advance directive;changes in sarcopenic obesity;All-casue mortality;Economic evaluation;Quality of Life;length of living at home;Visit to emergency room after disrcharge
© Copyright 2025. All Rights Reserved by MedPath